Adaptations of the pregnant murine heart to pre-existing hypertension
Elnaz Ghajar-RahimiiD, Arden Shen, Adalyn Meeks, Molly S. KaissariD, Shaheer K. FaruqiiD, Samantha Stebbings, Sarah Grev, Jake CastroiD, Abigail Cox, Kyoko YoshidaiD, Craig J. GoergeniD
Abstract
2-5% of pregnancies are complicated by chronic hypertension [1], increasing the risk of peripartum cardiomyopathy and maternal morbidity [2, 3]. Hypertension reduces stroke volume, whereas pregnancy increases stroke volume. The combined impact of these opposing loads on cardiac function and strain remains unclear. We used a mouse model of pregnancy with pre-existing hypertension to characterize cardiac remodeling. We hypothesized that pregnancy may counteract hypertension-related reductions in cardiac function. Nulliparous female C57Bl6/J mice (7-11 weeks old) were assigned into pregnant (PREG, n=11), angiotensin II-treated (ANGII, n=7), and ANGII+PREG (n=8) groups. Hypertension was induced with subcutaneous angII infusion (1000 ng/kg/min). Cardiac function was measured with high-frequency ultrasound. Ejection fraction (EF) was maintained in PREG animals at 65% but decreased significantly by day 36 in ANGII animals (44.85{+/-}3.27%). In ANGII+PREG mice, EF initially decreased but trended towards PREG values on postpartum day 1. Left ventricle strain was lower in ANGII and ANGII+PREG groups compared to PREG. ANGII and ANGII+PREG animals showed decreased early longitudinal diastolic strain rate at mid-pregnancy compared to baseline (0.82{+/-}0.09% ANGII; 0.73{+/-}0.09% ANGII+PREG), while increasing in PREG (1.76{+/-}0.14%). Minimal physiologically relevant fibrosis was noted across groups via immunohistochemistry. Heart mass-to-body mass was lowest in PREG (6.20{+/-}0.22 mg/g), greatest in ANGII (8.95{+/-}0.39 mg/g), and intermediate in ANGII+PREG (6.92{+/-}0.25 mg/g). Cardiomyocyte cross-sectional area was similar between groups. Overall, pregnancy altered the functional and hypertrophic response to elevated blood pressure. Findings from this work set the foundation for future efforts that may eventually improve cardiovascular care for pregnant patients.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pregnancy-Dependent Cardioprotection via GPER Activation in Dahl Salt-Sensitive Rats
Allan K. N. Alencar, Kenneth F. Swan, … Carolyn L. Bayer·bioRxiv·Apr 1, 2025
- Osteopontin Mediates Uterine Artery Dysfunction in Hypertensive Pregnancy
Megan L Lave, Jordan Jones, … Stephen James Renaud·American Journal of Physiology-Heart and Circulatory PhysiologyPeer-reviewed·Oct 26, 2026
- PKNs are required for cardiac hypertrophy induced by angiotensin II in mice
Susanna T.E. Cooper, Jacqueline J. T. Marshall, … Angela Clerk·bioRxiv·Oct 28, 2026
- Multiscale model of heart growth during pregnancy: Integrating mechanical and hormonal signaling
K. Yoshida, J. J. Saucerman, J. W. Holmes·bioRxiv·Sep 18, 2020
- Maternal cardiometabolic dysfunction and fetal sex-specific alterations to uterine vascular reactivity in an ovine model of diet-induced obesity during pregnancy
Rachael C. Crew, A. G. COCHRANE, … Dino A. Giussani·bioRxiv·Jan 16, 2026
- HUMAN FETAL CIRCULATING FACTORS FROM PREGNANCIES COMPLICATED BY MATERNAL OBESITY INDUCE HYPERTROPHY IN NEONATAL RAT CARDIOMYOCYTES
Owen R. Vaughan, Andrew Goodspeed, … Thomas Jansson·bioRxiv·Apr 16, 2025